USFDA completes inspection at Zydus Lifesciences’ SEZ Onco Injectable manufacturing plant

28 Mar 2024 Evaluate

United States Food and Drug Administration (USFDA) has completed inspection at Zydus Lifesciences’ SEZ Onco Injectable manufacturing plant at Ahmedabad. This cGMP USFDA inspection was conducted from March 18 to March 27, 2024. The inspection closed with 4 observations. There were no Data Integrity related observations. The Company will closely work with the USFDA to address the observations.

Zydus Lifesciences (formerly known as Cadila Healthcare) is an India-based pharmaceutical company.

Zydus Lifesciences Share Price

867.80 -16.20 (-1.83%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×